Skip to main content
OpenTrials

Clinical trial condition

Dyslipidemia

Explore clinical trials studying Dyslipidemia. Study availability and eligibility vary by location and protocol.

389 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Dyslipidemia trial results

Completed

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

NCT00442845

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
Locations
  • Pfizer Investigational Site Mississauga, Ontario, Cameroon
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Medicine Hat, Alberta, Canada
View all 121 locations
View Trial Details
Completed

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

NCT00412113

Conditions
Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Mesa, Arizona, United States
View all 51 locations
View Trial Details
Completed

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

NCT00150384

Conditions
Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Huntsville, Alabama, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
View all 106 locations
View Trial Details
Completed

Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia

NCT00330785

Conditions
Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
Locations
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Calgary, Alberta, Canada
View all 126 locations
View Trial Details
Completed

Caduet in an Untreated Subject Population

NCT00332761

Conditions
Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
Locations
  • Pfizer Investigational Site Jonesboro, Arkansas, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Garden Grove, California, United States
  • Pfizer Investigational Site Long Beach, California, United States
View all 34 locations
View Trial Details
Completed

Effects of Niacin On Fatty Acid Trapping

NCT01984073

Conditions
Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Presbyterian Hospital Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions